{"in_reply_to_user_id": "3108351", "lang": "en", "conversation_id": "1277559463889813505", "entities": {"mentions": [{"start": 0, "end": 4, "username": "WSJ", "id": "3108351"}], "annotations": [{"start": 5, "end": 9, "probability": 0.6911, "type": "Place", "normalized_text": "India"}, {"start": 13, "end": 27, "probability": 0.3718, "type": "Organization", "normalized_text": "Hetero Labs Ltd"}]}, "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "10029237524", "name": "The Wall Street Journal"}}], "reply_settings": "everyone", "public_metrics": {"retweet_count": 0, "reply_count": 1, "like_count": 4, "quote_count": 0}, "source": "Twitter for Android", "id": "1277568814188765186", "referenced_tweets": [{"type": "replied_to", "id": "1277559463889813505"}], "text": "@WSJ India\u2019s Hetero Labs Ltd has priced its generic version of remdesivir, Experimental Covid-19 drug, at 5,400 rupees ($71) per 100-milligram vial. Greed of capitalism wow...", "author_id": "152309214", "possibly_sensitive": false, "created_at": "2020-06-29T11:45:16.000Z"}